Furthermore, Kaplan–Meier analysis revealed that high expression of GPC1 and GPC2 were associated with shorter (P<0.01) overall survival in CRC patients (log-rank test) (Fig 1B). The gene discussed is GPC1; the disease is colorectal carcinoma.